Details of the Drug Reposition

General Information of This Drug (ID: DM0UL47)

Drug Name
Anti-PD-L1   DM0UL47
Synonyms BMS-936559
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Human immunodeficiency virus-1 infection DISRZ2R6 1C62 Phase 1 [1]
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01455103) Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma. U.S. National Institutes of Health.